# Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer

> **NCT00497107** · PHASE3 · UNKNOWN · sponsor: **Iwate Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** UFT, Calcium Folinate, PSK
- **DRUG:** UFT, Calcium Folinate

## Key facts

- **NCT ID:** NCT00497107
- **Lead sponsor:** Iwate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-07
- **Primary completion:** —
- **Final completion:** 2013-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2008-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497107, "Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00497107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*